HNGE shareholder plans $6.41M sale of 131,057 Class A shares

HNGE has a shareholder planning to sell 131,057 Class A shares through Merrill Lynch on the NYSE, with an aggregate market value of $6,409,997.87.

Rhea-AI Filing Summary

HNGE has a shareholder planning to sell 131,057 Class A shares through Merrill Lynch on the NYSE, with an aggregate market value of $6,409,997.87. The filing notes that 37,919,155 shares of this class are outstanding. The shares to be sold were originally acquired from the issuer in a private placement on 07/03/2018 for cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HNGE Class A shares are planned for sale?

The notice covers the planned sale of 131,057 Class A shares of HNGE.

What is the aggregate market value of the HNGE shares to be sold?

The 131,057 Class A shares have an aggregate market value of $6,409,997.87 according to the notice.

When are the HNGE shares expected to be sold and on which exchange?

The approximate date of sale is listed as 12/01/2025, and the shares are expected to be sold on the NYSE.

How and when were the HNGE shares originally acquired?

The 131,057 Class A shares were acquired on 07/03/2018 in a private placement from the issuer, with the purchase price paid in cash.

How many HNGE Class A shares are outstanding?

The filing states that there are 37,919,155 Class A shares outstanding.

Which broker is handling the planned HNGE share sale?

The planned sale is listed with Merrill Lynch, located at One Bryant Park, New York, NY 10036, as the broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/01/2025 - 05:21 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001710835
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	1114 Avenue of the Americas New York NEW YORK 10036
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Insight Venture Partners (Delaware) X, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Board Member

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Merrill Lynch One Bryant Park New York NY 10036	131057	6409997.87	37919155	12/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	07/03/2018	Private Placement	Issuer			131057	07/03/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	12/01/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Jonathan Grossman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)